Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer

被引：0
作者：
Andreas Ihrig
Pascal Marino Pernt
Stefanie Zschäbitz
Johannes Huber
Hans-Christoph Friederich
Till J. Bugaj
Imad Maatouk
机构：
[1] University Hospital Heidelberg,Division of Psycho
[2] National Centre for Tumor Diseases (NCT),Oncology, Department of General Internal Medicine and Psychosomatics
[3] University Hospital Heidelberg,Department of Medical Oncology
[4] Philipps-University Marburg,Department of Urology
[5] Julius-Maximilian University Würzburg,Section of Psychosomatic Medicine, Psychotherapy and Psycho
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
Metastatic prostate cancer; Hormonal agents; Androgen deprivation therapy; Neurocognitive effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2733 / 2739
页数：6
相关论文
共 50 条
  • [41] Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy
    Yee, Ellen F. T.
    White, Robert E.
    Murata, Glen H.
    Handanos, Christine
    Hoffman, Richard M.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (09) : 1305 - 1310
  • [42] Quality of life in prostate cancer patients taking androgen deprivation therapy
    Dacal, K
    Sereika, SM
    Greenspan, SL
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (01) : 85 - 90
  • [43] Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer
    Divrik, Rauf Taner
    Turkeri, Levent
    Sahin, Ali F.
    Akdogan, Bulent
    Ates, Ferhat
    Cal, Cag
    Baltaci, Sumer
    [J]. UROLOGIA INTERNATIONALIS, 2012, 88 (01) : 25 - 33
  • [44] Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health
    Bargiota, Alexandra
    Oeconomou, Athanasios
    Zachos, Ioannis
    Samarinas, Michel
    Pisters, Luis L.
    Tzortzis, Vassilios
    [J]. JOURNAL OF BUON, 2020, 25 (03): : 1286 - 1294
  • [45] Effects of androgen deprivation therapy on metabolic markers and bioelectrical impedance analyze in prostate cancer patients
    Cakici, Mehmet Caglar
    Can, Bulent
    Kazan, Ozgur
    Efiloglu, Ozgur
    Sendogan, Furkan
    Ucar, Taha
    Turan, Turgay
    Yildirim, Asif
    [J]. REVISTA INTERNACIONAL DE ANDROLOGIA, 2022, 20 (02): : 96 - 101
  • [46] Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy
    Palumbo, Isabella
    Ruggiero, Carmelinda
    Festa, Eleonora
    De Fano, Michelantonio
    Baroni, Marta
    Bellavita, Rita
    Ingrosso, Gianluca
    Saldi, Simonetta
    Duranti, Michele
    Mecocci, Patrizia
    Falorni, Alberto
    Aristei, Cynthia
    [J]. ANTICANCER RESEARCH, 2023, 43 (01) : 493 - 499
  • [47] Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?
    Klotz, L.
    Toren, P.
    [J]. CURRENT ONCOLOGY, 2012, 19 : S13 - S21
  • [48] Androgen deprivation therapy as backbone therapy in the management of prostate cancer
    Merseburger, Axel S.
    Alcaraz, Antonio
    von Klot, Christoph A.
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 7263 - 7274
  • [49] Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
    Hirata, Yu
    Shiota, Masaki
    Kobayashi, Takeshi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Eto, Masatoshi
    [J]. PROSTATE INTERNATIONAL, 2019, 7 (04) : 166 - 170
  • [50] Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
    Jonathan Kluger
    Alicia Roy
    Herta H. Chao
    [J]. Current Oncology Reports, 2020, 22
12345